Research DepartmentsPeoplePublicationsPostdoc & Student Positions  
 
 Cancer Endocrinology 
Hans Adomat
Publications
Publications

    1998

  1. Skov KA, Adomat H, Farrell NP, Matthews JB. Assessment of toxicity of bis-platinum complexes in hypoxic and aerobic cells. Anticancer Drug Des 13(3):207-20. (1998).
     [View Abstract - PubMed 9595034]

  2. 1996

  3. Marples B, Adomat H, Koch CJ, Skov KA. Response of V79 cells to low doses of X-rays and negative pi-mesons: clonogenic survival and DNA strand breaks. Int J Radiat Biol 70(4):429-36. (1996).
     [View Abstract - PubMed 8862454]

  4. Matthews J, Adomat H, Farrell N, King P, Koch C, Lord E, Palcic B, Poulin N, Sangulin J, Skov K. Immunocytochemical labelling of aerobic and hypoxic mammalian cells using a platinated derivative of EF5. Br J Cancer Suppl 27:S200-3. (1996).
     [View Abstract - PubMed 8763880]

  5. 1994

  6. Balansky R, Adomat H, Bryson L. Additive coclastogenicity of sodium selenite and caffeine in CHO cells treated with N-methyl-N'-nitro-N-nitrosoguanidine. Biol Trace Elem Res 42(1):53-61. (1994).
     [View Abstract - PubMed 7986661]

  7. Marples B, Adomat H, Billings PC, Farrell NP, Koch CJ, Skov KA. Recognition of platinum-induced DNA damage by nuclear proteins: screening for mechanisms. Anticancer Drug Des 9(5):389-99. (1994).
     [View Abstract - PubMed 7945723]

  8. Skov KA, Adomat H, Doedee M, Farrell N. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline]. Anticancer Drug Des 9(2):103-17. (1994).
     [View Abstract - PubMed 8166927]

  9. 1993

  10. Korbelik M, Krosl G, Adomat H, Skov KA. The effect of differentiation on photosensitizer uptake by HL60 cells. Photochem Photobiol 58(5):670-5. (1993).
     [View Abstract - PubMed 8284322]

  11. Matthews JB, Adomat H, Skov KA. The effect of hypoxia on cytotoxicity, accumulation and DNA binding of cisplatin in Chinese hamster ovary cells. Anticancer Drugs 4(4):463-70. (1993).
     [View Abstract - PubMed 8400349]

  12. Skov KA, Adomat H, Farrell NP. Radiosensitization by nickel lapachol. Int J Radiat Biol 64(6):707-13. (1993).
     [View Abstract - PubMed 7903338]

  13. 1990

  14. Skov KA, Adomat H, Chaplin DJ, Farrell NP. Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole. Anticancer Drug Des 5(1):121-8. (1990).
     [View Abstract - PubMed 2156514]

  15. 1987

  16. Skov KA, Adomat H, Konway DC, Farrell NP. Assessment of DNA binding of platinum-radiosensitizer complexes by inhibition of restriction enzymes. Chem Biol Interact 62(2):117-29. (1987).
     [View Abstract - PubMed 3036382]

  17. Skov KA, Farrell NP, Adomat H. Platinum complexes with one radiosensitizing ligand [PtCl2(NH3) (sensitizer)]: radiosensitization and toxicity studies in vitro. Radiat Res 112(2):273-82. (1987).
     [View Abstract - PubMed 3685256]

  18. 1982

  19. Rootman J, Josephy PD, Adomat H, Palcic B. Ocular absorption and toxicity of a radiosensitizer and its effect on hypoxic cells. Arch Ophthalmol 100(3):468-71. (1982).
     [View Abstract - PubMed 7199901]


Top of Page Prev (7 of 21) Next

URL: http://www.bccrc.ca/ce/pubs_hadomat.html
The BC Cancer Agency Research Centre is the research arm of the BC Cancer Agency (BCCA),
and is supported by the BC Cancer Foundation.
This page was last modified at 2:36pm on July 3, 2001
© 1999-2008. BC Cancer Agency. All rights reserved.
About this website...

 
Navigation Menu

View Site Map

Contact Us

BC Cancer Agency Research Centre
675 West 10th Avenue
Vancouver, BC
V5Z 1L3  Canada
1-604-675-8000


We subscribe to the HONcode principles of the Health On the Net Foundation